Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Macitentan tablets are an endothelin receptor antagonist (ERA) indicated for the treatment of pulmonary arterial hypertension (PAH, WHO Group I) in adults to reduce the risks of disease progression and hospitalization for PAH.
Macitentan tablets, 10 mg, have an estimated market size of $1,180 million for twelve months ending June 2025 according to IQVIA.
The pharmaceutical company has a cumulative total of 224 ANDA approvals (203 final approvals and 21 tentative approvals) from USFDA.
Alembic Pharmaceuticals is a vertically integrated research-driven company that manufactures and markets generic medicines globally.
The company's consolidated net profit jumped 14.6% to Rs 154.38 crore while revenue from operations grew 9.54% to Rs 1,710.72 crore in Q1 June 2025 over Q1 June 2024.
PG Electroplast, PNB Housing Finance, RBL Bank and Titagarh Rail Systems are banned from F&O trading on 14 August 2025.
Stocks to Watch:
Vodafone Idea’s consolidated basis, net loss stood at Rs 6,608.1 crore in Q1 FY26 higher than Rs 6,432.1 crore in Q1 FY25. Revenue from operations rose 4.9% YoY to Rs 11,022.5 crore from Rs 10,508.3 crore in Q1 FY25. Operationally, ARPU improved 15% YoY to Rs 177 from Rs 154 in Q1 FY25, driven by tariff revisions and customer upgrades. The 4G/5G subscriber base rose to 127.4 million versus 126.7 million last year.
Alembic Pharmaceuticals has received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Tretinoin Cream USP, 0.025%.
Ola Electric Mobility announced a series of product launches and technology updates at its annual Sankalp 2025 event. Ola entered the sports scooter category with the launch of the S1 Pro Sport, equipped with 5.2kWh and 4kWh battery packs.
Jyoti Structures reported a 119.25% surge in consolidated net profit to Rs 11.16 crore, driven by a 76.87% rise in revenue from operations to Rs 156.16 crore in Q1 FY26 over Q1 FY25.
Brahmaputra Infrastructure’s consolidated net profit soared 121.82% to Rs 15.04 crore in Q1 FY26 as against Rs 6.78 crore posted in Q1 FY25. Total income from operations jumped 16.07% year on year to Rs 92.14 crore in the quarter ended 30 June 2025.
Globe Civil Projects has secured an order worth Rs 222.19 crore from the Haryana Cricket Association for the construction of an international cricket stadium at Lohat, Jhajjar, Haryana.
Vipul Organics' consolidated net profit jumped 11.50% to Rs 1.26 crore in Q1 FY26 as against Rs 1.13 crore posted in Q1 FY25. However, revenue from operations jumped fell 1.23% year on year to Rs 37.59 crore in the quarter ended 30 June 2025.
Lemon Tree Hotels' material subsidiary, Fleur Hotels, has received a letter of award (LoA) from the Delhi Development Authority (DDA) for the licence rights to a prime land parcel in Nehru Place, New Delhi.
With this nod, Alembic’s cumulative ANDA approvals now stand at 224, including 202 final and 22 tentative approvals.
The company's consolidated net profit jumped 14.18% to Rs 156.63 crore while revenue from operations grew 9.54% to Rs 1,710.72 crore in Q1 June 2025 over Q1 June 2024.
Alembic Pharmaceuticals (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Tretinoin Cream USP, 0.025%. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Retin-A Cream, 0.025%, of Bausch Health US, LLC. Tretinoin cream is indicated for topical application in the treatment of acne vulgaris.
Tretinoin cream USP, 0.025%, has an estimated market size of US$ 94 million for twelve months ending June 2025 according to IQVIA.